Wikidata

(Q43250043)

English

Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial

scientific article published on 2 November 2009

In more languages

Statements

title
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
author
Vesa Kataja
object named as
Vesa Kataja
series ordinal
3
0 references
author name string
Tuomo Alanko
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Kari Möykkynen
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Seija Ingalsuo
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Mauri Huusko
series ordinal
14
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Tapio Salminen
series ordinal
15
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Hannu Leinonen
series ordinal
17
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
Mika Leinonen
series ordinal
18
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
publication date
2 November 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017
page(s)
5685-5692
1 reference
stated in
Europe PubMed Central
PubMed ID
19884557
retrieved
17 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43250043&oldid=2119133788"